Examination of dipeptides, amino-acids and substituted amino-acids for anti-inflammatory activity in carrageenan oedema.
D000284:Administration, Oral; D000596:Amino Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D002351:Carrageenan; D004151:Dipeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006146:Guanidines / Q000008:administration & dosage / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D008970:Molecular Weight; D010649:Phenylalanine / Q000008:administration & dosage / Q000627:therapeutic use; D051381:Rats; D014364:Tryptophan / Q000008:administration & dosage / Q000627:therapeutic use
D000596:Amino Acids; D004151:Dipeptides; D006146:Guanidines; D010649:Phenylalanine; D014364:Tryptophan; D002351:Carrageenan